SLAS Europe

June 26–28, 2019
Barcelona, Spain

Meet Genedata experts at SLAS Europe 2019 in Barcelona, Spain. Ask for a demonstration of Genedata Screener® and Genedata Imagence® at booth #201.

Don't miss the opportunity to see how Genedata Screener analyzes, visualizes, and manages screening data from in-vitro screening assay technologies across the enterprise, including very complex as well as ultra-high throughput experiments. Its screening-oriented business logic enables rapid processing and comprehensive analysis of complete campaigns. To schedule a meeting in advance or to receive more information on Genedata Screener, please contact

You also have a chance to find out more about our new solution, Genedata Imagence, a high content screening (HCS) image analysis software based on deep learning. To get more information about Imagence or to arrange a meeting, please contact

Recommended Oral Presentations

Friday, June 28, 2019

A Highly Automated End-to-End Analysis Workflow for High-Throughput Mass Spectrometry Screening
Heyse S., Operational Management, Genedata, Basel, Switzerland
Track: Automation and High-Throughput Technologies - User Machine Interactions
Room 113

Mass spectrometry (MS) features label-free, sensitive detection and rich output. Improved sampling and injection methods have made MS amenable for high-throughput screening. In a further advance, AstraZeneca (AZ) deployed Acoustic Mist Ionization Mass Spectrometry (AMI-MS) for production-scale screens. Leveraging AMI-MS’s potential required software infrastructure suited for high volumes of complex data. Genedata (GD) and AZ partnered to build an end-to-end HT-MS analysis workflow integrating GD Expressionist, an MS analysis software, and GD Screener, an analysis platform for in-vitro screening. The workflow loads raw data directly from the instrument and automates spectrogram processing and analysis, immediately delivering screening scientists at multiple research sites with pharmacologically meaningful endpoints, for quality control and hit triage. Overall, the solution enabled a 7-fold decrease in analysis time, preparing AZ to expand use of their innovative technology.

Recommended Poster Presentations

A Highly Automated End-to-End Analysis Workflow for High-Throughput Mass Spectrometry Screening
Steigele S., Bobby R., Sinclair I., Yee A.X., Wingfield J., Heyse S.
Poster #P039

A New Enterprise Software Platform for Efficient Large-Scale Antibody Characterization and Epitope Binning
Florez L., Florez J., Emkey R., Green L.B., Ginkel M., Yee A.X., Pfreundschuh M., Foster L., Heyse  S., and Steigele S.
Poster #P097